News Conference News TCT 2025 Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION Michael O'Riordan October 26, 2025
News Conference News ESC 2024 ‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS Michael O'Riordan September 09, 2024
News Daily News DES Best for In-Stent Restenosis, but DCBs Also Viable Michael O'Riordan August 13, 2024
News Conference News EuroPCR 2023 ‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise Michael O'Riordan May 18, 2023
News Conference News TCT 2021 Good Long-term Results With FANTOM BVS, but More Data Needed Michael O'Riordan October 21, 2021
News Conference News TCT 2019 PICCOLETO II: More Support for DCB Safety and Efficacy in Small Coronaries L.A. McKeown October 04, 2019
News Conference News EuroPCR 2017 Scaffold Thrombosis ‘Unpredictable’ With Absorb: AIDA Analysis Michael O'Riordan May 19, 2017
News Conference News TCT 2016 RIBS VI: Absorb BVS Safe in In-Stent Restenosis but Fails to Best Xience Metallic Stent Michael O'Riordan November 08, 2016
News Conference News TCT 2016 ‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent Michael O'Riordan October 30, 2016
News Conference News ESC 2015 ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff September 09, 2015
News Daily News RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis L.A. McKeown July 01, 2015
News Conference News TCT 2014 EVERBIO II: Angiographic Outcomes Similar for BVS, EES, BES September 17, 2014